Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): Differences among general practitioners, gastroenterologists and rheumatologists

European Journal of Clinical Pharmacology

Volumn 59, Issue 8-9, 2003, Pages 685-688

  Montastuc, J L ^a   Bongard, V ^a   Lapeyre Mestre, M ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Adverse drug reactions; Gastrointestinal haemorrhage; Non steroidal anti inflammatory drugs

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; INDOLE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

CLINICAL EDUCATION; CLINICAL PRACTICE; DRUG SAFETY; DRUG USE; EPIGASTRIC PAIN; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; HUMAN; MEDICAL SPECIALIST; NORMAL HUMAN; PAIN; PEPTIC ULCER; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VISUAL ANALOG SCALE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATTITUDE OF HEALTH PERSONNEL; CYCLOOXYGENASE INHIBITORS; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; RHEUMATOLOGY; RISK;

EID: 0345598094     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0648-5     Document Type: Review

References (14)

1. Bongard V, Menard-Taché S, Bagheri H, Lapeyre-Mestre M, Montastruc JL (2002) Perception of the risk of adverse drug reactions: differences between health and non health professionals. Br J Clin Pharmacol 54:433-436
2. Bussen M, Dunn APM (1986) Patients knowledge about prescribed medicines. Pharm J 236:624-626
3. Committee on Safety of Medicines update (1986) NSAID and serious gastrointestinal adverse drug reactions. Br Med J 292:614
4. Cosentino M, Leoni O, Oria C et al (1999) Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence. Pharmacoepidemiol Drug Saf 8:S27-S35
5. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH (1999) Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 48:623-627
6. Garcia-Rodriguez L, Hernandez-Diaz S (2001) The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res 3:98-101
7. Hernandez-Diaz S, Garcia-Rodriguez AL (2000) Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract. Bleeding/Perforation. Arch Intern Med 160:2093-2099
8. Juni P, Rutjes AWS, Dieppe PA (2002) Are selective cox-2 inhibitors superior to traditional non steroidal antiinflammatory drugs? Br Med J 324:1287-1288
9. Laporte JR, Carné X, Vidal X, Moreno V, Juan J (1991) Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 337:85-89
10. Montastruc JL (2002) Social pharmacology: a new topic in clinical pharmacology. Therapie 57:420-426
11. Moride Y, Haramburu F, Requejo AA, Begaud B (1997) Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol 43:177-181
12. Pouyanne P, Haramburu F, Imbs JL, Bégaud B (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. Br Med J 320:1036
13. Ribout S, Waters W, Georges CF (1986) Knowledge of and attitudes to medicines in the Southampton community. Br J Clin Pharmacol 21:701-702
14. Wynne HA, Long A (1996) Patient awareness of the adverse effects of non-steroidal antiinflammatory drugs (NSAIDs). Br J Clin Pharmacol 42:253-256